• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Clin Virol Plus . Severe acute respiratory syndrome coronavirus 2 seroprevalence survey among 10,256 workers in Kuwait

tetano

Editor, Senior Moderator
J Clin Virol Plus


. 2021 Jun;1(1):100017.
doi: 10.1016/j.jcvp.2021.100017. Epub 2021 May 3.
Severe acute respiratory syndrome coronavirus 2 seroprevalence survey among 10,256 workers in Kuwait


Haya Altawalah[SUP] 1 2 [/SUP], Wadha Alfouzan[SUP] 1 3 [/SUP], Rita Dhar[SUP] 3 [/SUP], Walid Alali[SUP] 4 5 [/SUP], Hamad Bastaki[SUP] 6 [/SUP], Talal Al-Fadalah[SUP] 7 [/SUP], Fahad Al-Ghimlas[SUP] 8 [/SUP], Ali A Rabaan[SUP] 9 [/SUP], Sayeh Ezzikouri[SUP] 10 [/SUP]



Affiliations

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has emerged as a global pandemic. Seroprevalence surveillance is urgently needed to estimate and monitor the growing burden of coronavirus disease 2019 (COVID-19). The aim of this study is to estimate the seroprevalence of SARS-CoV-2 infection among worker population residing in areas under lockdown in Kuwait and investigated their risk factors associated with a positive status. From April 18 to May 10, 2020 a randomly sampled, worker-based survey was conducted in 7 governorate in Kuwait (Ahmadi, Farwaniya, Hawali, Asma, Jahra, and Mubarak Alkabeer) among 10,256 workers. SARS-CoV-2 IgG and IgM antibodies was assessed using a commercially point-of-care lateral flow immunoassay (Biozek medical COVID-19 IgG/IgM Rapid Test Cassette). We estimated an overall seroprevalence (IgG or IgM positive) of 5.9% (95% CI: 5.4-6.3). Notably, SARS-CoV-2 seropositivity was significantly higher in males (6.2%) than females (1.9%) ( p < 0.001). Furthermore, the seroprevalence was significantly different by age group, governorate, and nationality of the workers. These results highlighted that the relatively low prevalence of anti-SARS-CoV-2 antibodies in hotspot areas in a specific population. Thus, we emphasize to repeat the serosurvey in the general population to assess the magnitude of viral spread and monitor the growing burden of COVID-19 in Kuwait.

Keywords: Antibodies; COVID-19; IgG and IgM; SARS-CoV-2; Seroprevalence; Workers.
 
Back
Top Bottom